Evergreen Therapeutics
Focus: Evergreen Therapeutics is an AI-driven pharmaceutical company headquartered in Hong Kong, currently operating a generic and specialty drug portfolio with significant exposure to post-LOE assets.
Profile data last refreshed 4d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Evergreen Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Evergreen Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$393K Part DDeclining
Post-LOE
HMG-CoA reductase inhibitor (statin) generating 100% of company revenue; modest Medicare Part D spend suggests minimal market traction.
Help build intelligence for Evergreen Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.